hiv Antibody
hiv Antibody
HIV p24 Antibody |
|||
| abx021867-1mg | Abbexa | 1 mg | 1612.8 EUR |
HIV p24 Antibody |
|||
| abx021868-1mg | Abbexa | 1 mg | 1612.8 EUR |
HIV-1 Antibody |
|||
| abx023021-1ml | Abbexa | 1 ml | 661.2 EUR |
Anti-HIV protease (HIV-1/HIV-2) Purified |
|||
| 11-302-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-HIV protease (HIV-1/HIV-2) Purified |
|||
| 11-302-C100 | ExBio | 0.1 mg | 200.4 EUR |
Anti-HIV p24 antibody |
|||
| 10-2842 | Fitzgerald | 1 mg | 360 EUR |
|
Description: Anti-HIV p24 Ag monoclonal antibody |
|||
Anti-HIV p24 antibody |
|||
| 10-2843 | Fitzgerald | 1 mg | 360 EUR |
|
Description: Anti-HIV p24 Ag monoclonal antibody |
|||
Anti-HIV p24 antibody |
|||
| 10-2844 | Fitzgerald | 1 mg | 360 EUR |
|
Description: Anti-HIV p24 Ag monoclonal antibody |
|||
Anti-HIV p24 antibody |
|||
| 10-2845 | Fitzgerald | 1 mg | 360 EUR |
|
Description: Anti-HIV p24 Ag monoclonal antibody |
|||
HIV-1 p24 Antibody |
|||
| 20-abx137062 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
| 20-abx137103 | Abbexa |
|
|
HIV-2 gp39 Antibody |
|||
| 20-abx137104 | Abbexa |
|
|
HIV-1 gp41 Antibody |
|||
| 20-abx137105 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
| 20-abx137183 | Abbexa |
|
|
HIV-1 gp41 Antibody |
|||
| 20-abx137196 | Abbexa |
|
|
HIV-2 gp39 Antibody |
|||
| 20-abx137197 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
| 20-abx137505 | Abbexa |
|
|
HIV-1 gp24 Antibody |
|||
| abx140209-01mg | Abbexa | 0.1 mg | 477.6 EUR |
HIV-1 p24 Antibody |
|||
| abx021869-1mg | Abbexa | 1 mg | 794.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021870-1mg | Abbexa | 1 mg | 760.8 EUR |
HIV-1 p24 Antibody |
|||
| abx021871-1mg | Abbexa | 1 mg | 794.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021872-1mg | Abbexa | 1 mg | 794.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021873-1mg | Abbexa | 1 mg | 794.4 EUR |
HIV-1 gp36 Antibody |
|||
| abx021875-1mg | Abbexa | 1 mg | 1387.2 EUR |
HIV-1 gp41 Antibody |
|||
| abx021876-1mg | Abbexa | 1 mg | 1554 EUR |
HIV-1 gp41 Antibody |
|||
| abx021877-100ug | Abbexa | 100 ug | 878.4 EUR |
HIV-1 gp41 Antibody |
|||
| abx021878-1mg | Abbexa | 1 mg | 1387.2 EUR |
HIV-1 p17 Antibody |
|||
| abx021881-100ug | Abbexa | 100 ug | 878.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021882-1mg | Abbexa | 1 mg | 1178.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021883-1mg | Abbexa | 1 mg | 1220.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021886-1mg | Abbexa | 1 mg | 1220.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021887-1mg | Abbexa | 1 mg | 1220.4 EUR |
HIV-1 p24 Antibody |
|||
| abx021888-1mg | Abbexa | 1 mg | 1220.4 EUR |
HIV-2 gp36 Antibody |
|||
| abx021891-100ug | Abbexa | 100 ug | 878.4 EUR |
HIV-1 Antibody (HRP) |
|||
| abx023019-1ml | Abbexa | 1 ml | 718.8 EUR |
HIV-1 gp120 Antibody |
|||
| abx023024-1ml | Abbexa | 1 ml | 777.6 EUR |
HIV-1 gp41 Antibody |
|||
| abx023025-1ml | Abbexa | 1 ml | 693.6 EUR |
HIV-1 p24 Antibody |
|||
| abx023027-1ml | Abbexa | 1 ml | 693.6 EUR |
HIV-1 p24 Antibody |
|||
| abx023925-1mg | Abbexa | 1 mg | 828 EUR |
HIV-1 p24 Antibody |
|||
| abx023926-1mg | Abbexa | 1 mg | 828 EUR |
HIV-1 p24 Antibody |
|||
| 7313-002mg | ProSci | 0.02 mg | 206.18 EUR |
|
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
|||
HIV-1 p24 Antibody |
|||
| 7313-01mg | ProSci | 0.1 mg | 523.7 EUR |
|
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
|||
Anti-HIV protease antibody |
|||
| STJ16100517 | St John's Laboratory | 100 µg | 487.2 EUR |
Anti-HIV protease (HIV-1/HIV-2) Purified Azide Free |
|||
| 10-302-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-HIV protease (HIV-1/HIV-2) Purified Azide Free |
|||
| 10-302-C100 | ExBio | 0.1 mg | 200.4 EUR |
HIV-1, HIV-2 Protease Substrate |
|||
| 5-01313 | CHI Scientific | 4 x 5mg | Ask for price |
HIV QK10 |
|||
| 5-01336 | CHI Scientific | 4 x 5mg | Ask for price |
HIV-1, HIV-2 Protease Substrate Peptide |
|||
| 20-abx265644 | Abbexa |
|
|
Anti-HIV/p24 monoclonal Antibody |
|||
| A1020-100 | Biovision | 444 EUR | |
anti-HIV p24 Monoclonal antibody |
|||
| 012-A-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
anti-HIV p24 Monoclonal antibody |
|||
| 012-A-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
Mouse antibody for HIV-1 |
|||
| 1943 | Virostat | 100 ug | 438.46 EUR |
|
Description: This is Mouse monoclonal FITC conjugated antibody against HIV-1 p24 for WB, ELISA. |
|||
HIV protease Antibody (Azide free) |
|||
| abx140182-01mg | Abbexa | 0.1 mg | 444 EUR |
HIV 1 / 2 p24 Antibody |
|||
| abx021866-1mg | Abbexa | 1 mg | 1212 EUR |
HIV-1 p24 Antibody (FITC) |
|||
| abx021884-100ug | Abbexa | 100 ug | 886.8 EUR |
HIV 1 / 2 p24 Antibody |
|||
| abx021890-1mg | Abbexa | 1 mg | 1212 EUR |
HIV-1 gp120 Antibody (Biotin) |
|||
| abx023022-1ml | Abbexa | 1 ml | 718.8 EUR |
HIV-1 gp120 Antibody (HRP) |
|||
| abx023023-1ml | Abbexa | 1 ml | 794.4 EUR |
HIV-1 p24 Antibody (FITC) |
|||
| abx023026-1ml | Abbexa | 1 ml | 678 EUR |
HIV-1 p24 Antibody (Biotin) |
|||
| abx023028-1ml | Abbexa | 1 ml | 794.4 EUR |
HIV-1 p24 Antibody (HRP) |
|||
| abx023029-1ml | Abbexa | 1 ml | 886.8 EUR |
Polyclonal HIV-1 p24 Antibody |
|||
| APR11116G | Leading Biology | 0.1 mg | 790.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIV-1 p24 . This antibody is tested and proven to work in the following applications: |
|||
p24-HIV(p24/661) Antibody |
|||
| BNC040661-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNC040661-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNC050661-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNC050661-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNCAP0661-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNCAP0661-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNCB0661-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL |
|||
p24-HIV(p24/661) Antibody |
|||
| BNCB0661-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL |
|||